Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Verna

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|April 26, 2023
Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group StudyRandi J Wong, Jin Ge, Justin Boike, et al.
Hepatology (Baltimore, Md.)|April 17, 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus StatementOren K Fix, Bilal Hameed, Robert J Fontana, et al.
JAMA Surgery|September 12, 2019
Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass IndexChristine E Haugen, Mara McAdams-DeMarco, Elizabeth C Verna, et al.
Journal of Hepatology|April 3, 2020
Changes in frailty are associated with waitlist mortality in patients with cirrhosisJennifer C Lai, Jennifer L Dodge, Matthew R Kappus, et al.
Journal of Hepatology|April 4, 2020
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohortElizabeth C Verna, Giuseppe Morelli, Norah A Terrault, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisJessica A Musto, Jens Eickhoff, Meritxell Ventura-Cots, et al.
Hepatology (Baltimore, Md.)|May 16, 2017
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET studyVarun Saxena, Vandana Khungar, Elizabeth C Verna, et al.
Hepatology (Baltimore, Md.)|December 4, 2021
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) StudyJennifer C Lai, Amy M Shui, Andres Duarte-Rojo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2020
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic dataStephen M Lagana, Satoru Kudose, Alina C Iuga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) StudyChelsea Q Xu, Yara Mohamad, Matthew R Kappus, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
Journal of Vascular and Interventional Radiology : JVIR|April 26, 2023
Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group StudyRandi J Wong, Jin Ge, Justin Boike, et al.
Hepatology (Baltimore, Md.)|April 17, 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus StatementOren K Fix, Bilal Hameed, Robert J Fontana, et al.
JAMA Surgery|September 12, 2019
Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass IndexChristine E Haugen, Mara McAdams-DeMarco, Elizabeth C Verna, et al.
Journal of Hepatology|April 3, 2020
Changes in frailty are associated with waitlist mortality in patients with cirrhosisJennifer C Lai, Jennifer L Dodge, Matthew R Kappus, et al.
Journal of Hepatology|April 4, 2020
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohortElizabeth C Verna, Giuseppe Morelli, Norah A Terrault, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisJessica A Musto, Jens Eickhoff, Meritxell Ventura-Cots, et al.
Hepatology (Baltimore, Md.)|May 16, 2017
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET studyVarun Saxena, Vandana Khungar, Elizabeth C Verna, et al.
Hepatology (Baltimore, Md.)|December 4, 2021
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) StudyJennifer C Lai, Amy M Shui, Andres Duarte-Rojo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2020
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic dataStephen M Lagana, Satoru Kudose, Alina C Iuga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) StudyChelsea Q Xu, Yara Mohamad, Matthew R Kappus, et al.
Pageof 23